2009CCO/PET成像用于胰腺癌診斷
《2009CCO/PET成像用于胰腺癌診斷》內(nèi)容簡介：
In some cases where sufficient evidence existed, meta-**yses were included withpooled likelihood ratios. The AHRQ review included evidence tables that summarized thecharacteristics and results of each study according to the outcomes the study addressed. Fordiagnostic performance, the evidence tables recorded details on the source of the publicationand the evidence grade, study design, patient characteristics, PET technical characteristics,criteria for interpretation, and results.
《2009CCO/PET成像用于胰腺癌診斷》內(nèi)容預(yù)覽：
Provincial Consensus Process
The consensus meeting on 25 November 2008 was conducted as follows:
Presentations by each of the clinical lead authors on the DRAFT DSG recommendations
and supporting evidence were made to the meeting participants.
The recommendations were refined by the large group, and in some cases a revised
recommendation was proposed, resulting in a FINAL recommendation.
The participants voted on the FINAL recommendations to indicate their extent of
agreement on a scale from 1 to 7 （1 indicating strong agreement, 5 indicating no
agreement or disagreement, and 7 indicating strong disagreement）。
RESULTS
Literature Search Results
The AHRQ review results for pancreatic cancer included 17 primary studies. Data from
the evidence tables are summarized in Appendix 1. In addition to data for diagnostic
performance, summaries of results for diagnostic thinking and management strategy are also
presented where they apply. The key evidence is described below in an abbreviated fashion.
Key Evidence
Diagnosis/Staging
Eleven prospective studies were identified that evaluated the role of PET or PET/CT in the
diagnosis of a suspicious pancreatic mass. Sensitivity ranged from 69% to 97%, and
specificity ranged from 61% to 97% （Giorgi2004 [3], Nishiyama2005-100 [4], Rasmussen2004
[5], van Kouwen2005 [6], Bang2006 [7], Heinrich2005 [8], Lemke2004 [9], Lytras2005 [10],
Maemura2006 [11], Sperti2007 [12], Casneuf2007 [13]）。
點擊下載***：《2009CCO/PET成像用于胰腺癌診斷》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進(jìn)行刪除處理
- 相關(guān)閱讀
- ·血清脂肪酶臨床意義
- ·胰島素瘤臨床表現(xiàn)
- ·胰腺癌的診斷
- ·血清脂肪酶的臨床意義
- ·臨床執(zhí)業(yè)醫(yī)師考試-糖尿病導(dǎo)致胰腺癌知識點
熱點圖文
-
2013我國胰腺囊性腫瘤共識意見草案
本共識意見（草案）依據(jù)我國胰腺囊性腫瘤的最近研究，并參考國際相關(guān)指南和研究...[詳細(xì)]
-
2013NCCN結(jié)直腸癌指南
在美國，結(jié)直腸癌發(fā)病率占所有癌癥的第四位，而死亡率為第二位。2012年估計...[詳細(xì)]
